Answers are grounded in this paper and cite their sources.
Review discusses molecular design strategies for enhancing biological functions in various biomedical applications, suggesting future advancements.
The regulation of cellular signaling relies fundamentally on molecular recognition. However, the direct application of natural biomolecules is often limited by poor stability, insufficient specificity, and inadequate controllability. Rational molecular design has therefore emerged as an effective approach to bridge chemical structure and biological function, enabling the development of engineered systems with programmable recognition and tunable bioactivity. This review provides a function-oriented perspective on molecular imprinting, affinity screening, dynamic combinatorial chemistry, and biomolecular modification. These approaches enable the construction of synthetic or semi-synthetic macromolecules with tailored affinity, multivalency, and environmental responsiveness. Such engineered systems generate diverse biofunctional outputs, including signal interception, receptor clustering, and adaptive regulation, thereby enabling precise modulation of cellular signaling pathways. Furthermore, this review highlights the recent advances in applying these design principles to biomedical scenarios, including intelligent drug delivery, immunotherapy, and tissue engineering. Finally, the current technological challenges are summarized in vivo stability, insufficient spatiotemporal control, and barriers to clinical translation. Future efforts will likely focus on the development of adaptive and integrative molecular systems with enhanced precision and controllability, enabling the rational programming of biological functions and accelerating their clinical translation.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: